Natural products targeting the MAPK-signaling pathway in cancer: overview

Purpose This article summarizes natural products that target the MAPK-signaling pathway in cancer therapy.

The classification, chemical structures, and anti-cancer mechanisms of these natural products are elucidated, and comprehensive information is provided on their potential use in cancer therapy.

Methods Using the PubMed database, we searched for keywords, including “tumor”, “cancer”, “natural product”, “phytochemistry”, “plant chemical components”, and “MAPK-signaling pathway”.

We also screened for compounds with well-defined structures that targeting the MAPK-signaling pathway and have anti-cancer effects.

We used Kingdraw software and Adobe Photoshop software to draw the chemical compound structural diagrams.

Results A total of 131 papers were searched, from which 85 compounds with well-defined structures were selected.

These compounds have clear mechanisms for targeting cancer treatment and are mainly related to the MAPK-signaling pathway.

Examples include eupatilin, carvacrol, oridonin, sophoridine, diosgenin, and juglone.

These chemical components are classified as flavonoids, phenols, terpenoids, alkaloids, steroidal saponins, and quinones.

Conclusions Certain MAPK pathway inhibitors have been used for clinical treatment.

However, the clinical feedback has not been promising because of genomic instability, drug resistance, and side effects.

Natural products have few side effects, good medicinal efficacy, a wide range of sources, individual heterogeneity of biological activity, and are capable of treating disease from multiple targets.

These characteristics make natural products promising drugs for cancer treatment.